Researchmoz added Most up-to-date research on "Infectious Disease Treatment Market in China 2016-2020" to its huge collection of research reports.
Infectious diseases are caused by pathogenic microorganisms such as bacteria, parasites, fungi, or viruses. They can be transmitted from one person to another through direct or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on target organism, anti-infective drugs can be categorized into antibacterial, antifungal, antiviral, and antiparasitic.
Technavios analysts forecast the infectious disease treatment market in China to grow at a CAGR of 5.01% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the infectious disease treatment market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat infectious diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=729259
Technavio's report, Infectious Disease Treatment Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
F. Hoffmann-La Roche
Gilead Sciences
GSK
Johnson & Johnson
Merck
Pfizer
Other prominent vendors
Achaogen
Actelion
Adenovir Pharma
AstraZeneca
Bayer
Biocryst
Celsus therapeutics
Cempra
Eleven Biotherapeutics
Exoxemis
Ferrer International
Griffin Discoveries
Hexima
InSite Vision
Insmed Incorporated
KaloBios Pharmaceuticals
Lytix Biopharma
Meiji Seika Pharma
Melinta Therapeutics
Moberg Pharma
NanoViricides
Nektar
NicOx
NovaBay
NovaBiotics
Ocular Therapeutix
Panoptes Pharma
Paratek Pharmaceuticals
Polichem
PTC Therapeutics
RedHill
Shire
Starpharma Holdings
Sun Pharma
Symbiomix
Tetraphase Pharmaceuticals
The Medicines Company
Theravance Biopharma
Topica Pharmaceuticals
Vertex Pharmaceuticals
Viamet Pharmaceuticals
Market driver
Use of combination therapies
For a full, detailed list, view our report
Market challenge
Development of drug resistant strains
For a full, detailed list, view our report
Market trend
Emergence of interferon (IFN)-free therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=729259
Infectious diseases are caused by pathogenic microorganisms such as bacteria, parasites, fungi, or viruses. They can be transmitted from one person to another through direct or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on target organism, anti-infective drugs can be categorized into antibacterial, antifungal, antiviral, and antiparasitic.
Technavios analysts forecast the infectious disease treatment market in China to grow at a CAGR of 5.01% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the infectious disease treatment market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat infectious diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=729259
Technavio's report, Infectious Disease Treatment Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
F. Hoffmann-La Roche
Gilead Sciences
GSK
Johnson & Johnson
Merck
Pfizer
Other prominent vendors
Achaogen
Actelion
Adenovir Pharma
AstraZeneca
Bayer
Biocryst
Celsus therapeutics
Cempra
Eleven Biotherapeutics
Exoxemis
Ferrer International
Griffin Discoveries
Hexima
InSite Vision
Insmed Incorporated
KaloBios Pharmaceuticals
Lytix Biopharma
Meiji Seika Pharma
Melinta Therapeutics
Moberg Pharma
NanoViricides
Nektar
NicOx
NovaBay
NovaBiotics
Ocular Therapeutix
Panoptes Pharma
Paratek Pharmaceuticals
Polichem
PTC Therapeutics
RedHill
Shire
Starpharma Holdings
Sun Pharma
Symbiomix
Tetraphase Pharmaceuticals
The Medicines Company
Theravance Biopharma
Topica Pharmaceuticals
Vertex Pharmaceuticals
Viamet Pharmaceuticals
Market driver
Use of combination therapies
For a full, detailed list, view our report
Market challenge
Development of drug resistant strains
For a full, detailed list, view our report
Market trend
Emergence of interferon (IFN)-free therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=729259
No comments:
Post a Comment